1 / 1

Natural carnosine β -alanyl-L-Histidine

Natural carnosine β -alanyl-L-Histidine. Unatural carnosine β -alanyl-D-Histidine. Hystidine and deuterium labelled hystidine by asymmetric catalytic reduction with gaseous H2 or D2; role of strong non coordinating acids. E.Cesarotti, I.Rimoldi, D. Zerla

grover
Download Presentation

Natural carnosine β -alanyl-L-Histidine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Natural carnosine β-alanyl-L-Histidine Unatural carnosine β-alanyl-D-Histidine Hystidine and deuterium labelled hystidine by asymmetric catalytic reduction with gaseous H2 or D2; role of strong non coordinating acids. E.Cesarotti, I.Rimoldi, D. Zerla Università di Milano, Facoltà di Farmacia, Dipartimento di Chimica Inorganica, Metallorganica e Analitica. Human serum carnosinase Cytotoxic compounds oxidative damage Non toxic products Carnosine is an endogenous dipeptide presents in the human muscles and nerve tissue. It has the ability to react with toxic aldehydes deriving from metabolic pathway of oxidative degradation of endogenous compounds and so it has a protective and detoxifying effect on the toxic metabolites. D-Carnosine is cited as an equivalent to L-carnosine, but due to its favourable pharmacokinetic properties, durability to hydrolysis by the carnosinases, and stability in the plasma, D-carnosine seems to produce better therapeutic results than the L-form. To study the bioavailability and pharmacokinetic profile of D-carnosine, a deuterium labelled derivative is needed to be distinguished by endogenous L-carnosine in LC–MS experiments. Non coordinating strong acid like HBF4 are necessary for the catalytic hydrogenation of (Z)-methyl 2-benzamido-3-(1H-imidazol-5-yl)acrylate (1); only when the ratio HBF4/substate is 4:1 or higher the reaction is quantitatively and highly stereoselective. The role of strong acid is the protonation of the basic nitrogen atom, which if not protonated, could coordinate to the metal giving a stable catalytically inactive complex. E. Cesarotti, I. Rimoldi, D.Zerla, G. Aldini; Tetrahedron: Asymmetry, Volume 19 (2008), Issue 3, 273-278. Commercially available ligands used in asymmetic hydrogenation; all reactions were performed in methanol at 293°K under 1 bar of H2 How type and ratio of non coordinating acids influence activity and enantioselectivity of the catalytic system?

More Related